Skip to main content

John Hennessy, MBA

BDHC Thumbnail
Videos
01/09/2025
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the evolution and challenges of alternative payment models, including accountable care organizations (ACOs), the Oncology Care Model (OCM),...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the evolution and challenges of alternative payment models, including accountable care organizations (ACOs), the Oncology Care Model (OCM),...
In this Breaking Down Health...
01/09/2025
Cancer Care Business Exchange
Hennessy Headshot
Videos
12/10/2024
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses...
12/10/2024
First Report Managed Care
BDHC thumbnail
Videos
12/05/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, explore the distinction between precision and personalized medicine, the challenges and nuances of next-generation sequencing (NGS) testing in...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, explore the distinction between precision and personalized medicine, the challenges and nuances of next-generation sequencing (NGS) testing in...
In this Breaking Down Health...
12/05/2024
Cancer Care Business Exchange
BDHC Thumbnail
Breaking Down Health Care
11/07/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health...
11/07/2024
Cancer Care Business Exchange
Videos
11/04/2024
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at...
11/04/2024
Journal of Clinical Pathways
Cancer Care At Home
Videos
08/18/2023
CBEx Advisory Board Member John Hennessy, MBA, Valuate Health Consultancy, previews his featured CPC+CBEx meeting session, “Cancer Care at Home: Opportunities, Risks, and How to Prepare.”
CBEx Advisory Board Member John Hennessy, MBA, Valuate Health Consultancy, previews his featured CPC+CBEx meeting session, “Cancer Care at Home: Opportunities, Risks, and How to Prepare.”
CBEx Advisory Board Member John...
08/18/2023
Cancer Care Business Exchange
John Hennessy Headshot
Videos
10/24/2023
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey,...
10/24/2023
First Report Managed Care
John Hennessy
Videos
01/18/2024
John Hennessy, MBA, details his highlights from CPC+CBEx 2023 and answers questions related to cancer care, industry consolidation, and the future of cancer care at home.
John Hennessy, MBA, details his highlights from CPC+CBEx 2023 and answers questions related to cancer care, industry consolidation, and the future of cancer care at home.
John Hennessy, MBA, details his...
01/18/2024
Journal of Clinical Pathways
Stop-Loss Insurance, Explained Thumbnail
Videos
08/07/2023
John Hennessy, MBA, Valuate Health Consultancy, gives an overview of stop-loss or provider-excess insurance: what it is, why more oncology providers are considering it, and the pros and cons.
John Hennessy, MBA, Valuate Health Consultancy, gives an overview of stop-loss or provider-excess insurance: what it is, why more oncology providers are considering it, and the pros and cons.
John Hennessy, MBA, Valuate...
08/07/2023
Cancer Care Business Exchange
John Hennessy Headshot
Videos
08/28/2023
John Hennessy, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
John Hennessy, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
John Hennessy, MBA, Valuate...
08/28/2023
Cancer Care Business Exchange